TEVA
Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 9.70$. Average daily volumn in 3 months 9.36M. Market cap 11.02B
Stock symbol : TEVA. Exchange : NYSE. Currency : USD Lastest price : 9.92$. Total volume : 20.29M. Market state POST Click reload if you want to check the lastest price on market!!!
Teva Pharmaceutical Industries Limited (TEVA)
Last Price
9.92$Change
-0.97Volume
20.29M
| Previous Close | 10.89 |
| Open | 10.43 |
| Day Range | 9.90-10.46 |
| Bid | 9.88 x 3k |
| Ask | 9.92 x 2.2k |
| Volume | 20.29M |
| Average Volume | 9.36M |
| Market Cap | 11.02B |
| Beta | N/A |
| 52 Week Range | 6.78-11.45 |
| Trailing P/E | N/A |
| Foward P/E | 3.94 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | 2017-11-27 |
Financial Details
Organization
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells ac... tive pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Market Cap:
11.02B
News about "Teva Pharmaceutical Industries Limited"
Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript
Source from : The Motley Fool on MSN - 10 hours ago
Q4 2022 Earnings Call Feb 08, 2023, 8:00 a.m. ET Operator Load Error Good day and thank you for standing by. Welcome to Teva's fourth-quarter and full-year 2022 earnings call. [Operator instructions] ...See details»
Teva Pharma Posts Lower Q4 Earnings, FY23 Outlook Within Expectations
Source from : MSN - 14 hours ago
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q4 sales reached $3.88 billion, shrinking 5% Y/Y, missing the consensus of $3.93 billion. The decrease is mainly due to lower revenues from generic ...See details»
Teva Issues FY23 Adj. Earnings, Revenue Outlook - Update
Source from : Business Insider - 18 hours ago
Teva Pharmaceutical Industries Limited (TEVA), while announcing sharply wider net loss and weak revenues in its fourth quarter, ...See details»
Teva Pharmaceutical Industries Limited (NYSE: TEVA)’s Stock Reduces -0.60%, Making It A Good Investment
Source from : stocksregister - 2 days ago
The trading price of Teva Pharmaceutical Industries Limited (NYSE:TEVA) floating lower at last check on Monday, February 06, closing at $10.69, -0.60% lower than its previous close. Traders who pay ...See details»
Teva Pharmaceutical Industries Ltd
Source from : Newsweek - 23 days ago
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests ...See details»
Teva Pharmaceutical Industries Limited (TEVA) and the Battle of Fundamentals vs. Technicals
Source from : newsheater - 6 month ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA) went up by 0.69% from its latest closing price compared to the recent 1-year high of $11.44. The company’s stock price has collected -2.65% of loss ...See details»
Teva Reports Fourth Quarter and Full Year 2022 Financial Results
Source from : YAHOO!Finance - 19 hours ago
TEL AVIV, Israel, February 08, 2023--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2022.See details»
TEVA Teva Pharmaceutical Industries Limited
Source from : Seeking Alpha - 17 days ago
**NM signifies a non meaningful value. A dash signifies the data is not available.See details»
Teva Pharmaceutical Industries Ltd. (TEVA) CEO Richard Francis Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)
Source from : Seeking Alpha - 28 days ago
Teva is the largest supply chain manufacturing company in the entire pharmaceutical industry. Across 37,000 employees, with 53 manufacturing sites, we're working around the clock to make sure that ...See details»
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar?
Source from : Yahoo - 1 month ago
Teva Pharmaceutical Industries Ltd. TEVA shares ended the last trading session 5.5% higher at $10.52. The jump came on an impressive volume with a higher-than-average number of shares changing ...See details»
Teva Pharmaceutical Industries Limited (NYSE: TEVA)’S Stock Adds 2.73%, But It May Be Worth Investing In
Source from : stocksregister - 7 days ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA) price closed higher on Tuesday, January 31, jumping 2.73% above its previous close. A look at the daily price movement shows that the last close ...See details»
Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now?
Source from : Yahoo Finance - 12 days ago
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teva Pharmaceutical Industries Ltd. (TEVA) : Free Stock Analysis Report To read this article on Zacks.com ...See details»
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Source from : Nasdaq - 10 years ago
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...See details»
Teva Pharmaceutical Industries Ltd.
Source from : Wall Street Journal - 17 days ago
Vergis Independent Director Dentsply Sirona, Inc., Teva Pharmaceutical Industries Ltd., Dentsply Sirona France SAS, SGS SA, National Association of Corporate Directors, Church & Dwight Co., Inc ...See details»